Management of Chronic Disseminated Intravascular Coagulation Associated with Aortic Aneurysm/Dissection

Figure 2

Clinical course correlation of treatment and improvement of DIC-related data in Patient 1. (Vertical axis) FDP = fibrin degradation product (µg/ml); D-dimer (µg/ml); fibrinogen (mg/dl); Plt = platelet count (x10e4/µl). (Horizontal axis) days; Hp = heparin: Hp1 = continuous intravenous infusion (10,000 U/day), Hp2 = continuous intravenous infusion (8,000 U/day), and Hp3 = subcutaneous administration (5,000 U twice daily); TA = tranexamic acid: TA1 = intravenous infusion (250 mg twice daily),  = intravenous TA (250 mg twice daily) + oral TA (750 mg/day), TA2 = oral (750 mg/day), and TA3 = oral (1500 mg/day); WF = warfarin oral; RIV = rivaroxaban oral (15 mg/day).